Brief: Ainos Inc Receives IRB Approval From National Taiwan University Hospital For Hiv-Oral Warts Clinical Trial
25/09/2024 13:24
Sept 25 (Reuters) - Ainos Inc AIMD.O :
* AINOS INC: RECEIVES IRB APPROVAL FROM NATIONAL TAIWAN
UNIVERSITY
HOSPITAL FOR HIV-ORAL WARTS CLINICAL TRIAL
* AINOS INC: NEXT STEP WILL BE RECEIVING APPROVAL FROM
TAIWAN
FOOD AND DRUG ADMINISTRATION (TFDA)
Source text for Eikon: ID:
Further company coverage: AIMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ainos
See all newsAinos Q1 loss narrows as costs fall
Brief: Ainos On Dec 30 2025, Enters Distribution Agreement With Trusval Technology
Brief: Ainos Inc Receives IRB Approval From National Taiwan University Hospital For Hiv-Oral Warts Clinical Trial
Brief: Ainos Announces Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome
Brief: Ainos Secures Taiwan Invention Patent And Advances Global Patent Protection For Veldona